IDNA vs. MHIP
IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) and MHIP (Milliman Healthcare Inflation Plus ETF) are both Health & Biotech Equities funds. IDNA is passively managed, while MHIP is actively managed. A 0.65 correlation means they provide meaningful diversification when combined. IDNA charges 0.47%/yr vs 0.55%/yr for MHIP.
Performance
IDNA vs. MHIP - Performance Comparison
Loading charts...
Returns By Period
IDNA
- 1D
- -1.79%
- 1M
- 11.15%
- 6M
- 19.72%
- YTD
- 26.34%
- 1Y
- 57.08%
- 3Y*
- 12.75%
- 5Y*
- -6.42%
- 10Y*
- —
MHIP
- 1D
- -0.57%
- 1M
- 1.53%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IDNA vs. MHIP - Yearly Performance Comparison
Correlation
The correlation between IDNA and MHIP is 0.65, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Apr 21, 2026 | 0.65 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IDNA vs. MHIP — Risk / Return Rank
IDNA
MHIP
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
IDNA vs. MHIP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and Milliman Healthcare Inflation Plus ETF (MHIP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IDNA | MHIP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.36 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 5.38 | — | — |
| Martin ratioReturn relative to average drawdown | 14.96 | — | — |
Loading charts...
Drawdowns
IDNA vs. MHIP - Drawdown Comparison
The maximum IDNA drawdown since its inception was -68.26%, which is greater than MHIP's maximum drawdown of -3.09%. Use the drawdown chart below to compare losses from any high point for IDNA and MHIP.
Loading charts...
Drawdown Indicators
| IDNA | MHIP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.26% | -3.09% | -65.17% |
Max Drawdown (1Y)Largest decline over 1 year | -10.66% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -29.46% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -68.26% | — | — |
Current DrawdownCurrent decline from peak | -37.71% | -1.48% | -36.23% |
Average DrawdownAverage peak-to-trough decline | -36.28% | -1.25% | -35.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.83% | — | — |
Volatility
IDNA vs. MHIP - Volatility Comparison
Loading charts...
Volatility by Period
| IDNA | MHIP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.23% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 18.68% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 25.27% | 11.73% | +13.54% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.52% | 11.73% | +16.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.51% | 11.73% | +17.78% |
IDNA vs. MHIP - Expense Ratio Comparison
IDNA has a 0.47% expense ratio, which is lower than MHIP's 0.55% expense ratio.
Dividends
IDNA vs. MHIP - Dividend Comparison
IDNA's dividend yield for the trailing twelve months is around 0.85%, while MHIP has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 0.85% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
MHIP Milliman Healthcare Inflation Plus ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
IDNA and MHIP have a correlation of 0.65, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, IDNA is cheaper at 0.47% per year. The better choice depends on whether you care most about return, fees, risk, or income.
IDNA is cheaper with a 0.47% expense ratio, compared with 0.55% for MHIP.
IDNA has the higher dividend yield at 0.85%, compared with 0.00% for MHIP.
They also come from different issuers: iShares and Milliman. Their fees differ too: 0.47% for IDNA and 0.55% for MHIP.
Find the right allocation for IDNA and MHIP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer